Wealth Enhancement Advisory Services LLC Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Wealth Enhancement Advisory Services LLC bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 6,583 shares of the company’s stock, valued at approximately $206,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Massachusetts Financial Services Co. MA acquired a new stake in Option Care Health during the 2nd quarter valued at approximately $68,003,000. Magnetar Financial LLC grew its position in shares of Option Care Health by 124.8% during the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock worth $68,750,000 after buying an additional 1,377,929 shares in the last quarter. Duquesne Family Office LLC increased its stake in shares of Option Care Health by 172.8% in the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock worth $51,849,000 after buying an additional 1,185,613 shares during the last quarter. Hood River Capital Management LLC increased its stake in shares of Option Care Health by 77.2% in the second quarter. Hood River Capital Management LLC now owns 1,729,029 shares of the company’s stock worth $47,894,000 after buying an additional 753,208 shares during the last quarter. Finally, Westfield Capital Management Co. LP raised its holdings in Option Care Health by 15.4% in the first quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock valued at $173,448,000 after acquiring an additional 688,653 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Option Care Health

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on OPCH shares. JMP Securities boosted their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $38.00 to $27.00 in a report on Monday, November 4th. Truist Financial reduced their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Finally, Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $30.83.

Option Care Health Stock Down 0.0 %

NASDAQ:OPCH opened at $22.85 on Wednesday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a 50 day moving average of $29.43 and a 200-day moving average of $29.59. The firm has a market capitalization of $3.89 billion, a PE ratio of 19.21, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32. Option Care Health, Inc. has a 52 week low of $22.25 and a 52 week high of $34.63.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.